| 摘要 |
<p>The present invention relates to combinations suitable for the treatment of neurological/psychiatric disorders, in particular affective and attention disorders. The combination comprise at least one AMPA receptor antagonist and at least one compound selected from the group consisting of lithium, valproic acid sodium salt, conventional antipsychotics, atypical antipsychotics, lamotrigine, methylphenidate, antidepressants and antiepileptics.</p> |
| 申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;LINGENHOEHL, KURT;MARTENYI, FERENC;OFNER, SILVIO;KAROLCHYK, MARY ANN;KALKMAN, HANS, O.;AITKEN, DAVID |
发明人 |
LINGENHOEHL, KURT;MARTENYI, FERENC;OFNER, SILVIO;KAROLCHYK, MARY ANN;KALKMAN, HANS, O.;AITKEN, DAVID |
